secwatch.observer — SEC 8-K summary
======================================

Issuer:     Traws Pharma, Inc. (TRAW)
CIK:        0001130598
Form:       8-K
Filed at:   2023-08-15T23:59:59+00:00
Accession:  0001104659-23-091958
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Onconova stockholders elect eight directors, approve say-on-pay and auditor ratification at 2023 annual meeting
--------------------------------------------------------------------------------

- Elected all eight director nominees with majority 'For' votes; broker non-votes 3,588,614 each.
- Advisory say-on-pay approved: 4,959,016 For, 1,066,808 Against, 900,578 Abstain.
- Ratification of Ernst & Young as auditor approved: 9,271,526 For, 368,397 Against, 875,093 Abstain.
- Quorum achieved with 10,515,016 shares represented after prior adjournment on July 21, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130598/000110465923091958/0001104659-23-091958-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130598/000110465923091958/tm2323845d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-091958

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer